MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/ejhf.3290

Медицинская библиотека · European journal of heart failure · 2024

Measuring congestion with a non-invasive monitoring device in heart failure and haemodialysis: CONGEST-HF.

Curtain James P, Talebi Atefeh, McIntosh Alasdair, McConnachie Alex, O'Donnell Joanne, Welsh Paul, Osmanska Joanna, Lee Matthew M Y, Sonecki Piotr, Akl Tony, Seo Joohyun, Gopinathan Venugopal, Hurwitz Jed, Thiagarajan Srikanth, Pettit Stephen, Kalra Paul R, Patel Rajan K, Mark Patrick B, Lang Ninian N, McMurray John J V, Petrie Mark C, Gardner Roy S, Jhund Pardeep S

СтатьяПеревод пока не подготовлен

Аннотация

AIMS: We examined the effectiveness of a novel cardiopulmonary management wearable sensor (worn for less than 5 mins) at measuring congestion and correlated the device findings with established clinical measures of congestion.

METHODS AND

RESULTS

We enrolled three cohorts of patients: (1) patients with heart failure (HF) receiving intravenous diuretics in hospital; (2) patients established on haemodialysis, and (3) HF patients undergoing right heart catheterization (RHC). The primary outcomes in the respective cohorts were a Spearman correlation between (1) change in weight and change in thoracic impedance (TI) (from enrolment, 24 h after admission to discharge) in patients hospitalized for HF; (2) lung ultrasound B-lines and volume removed during dialysis with device measured TI, and (3) pulmonary capillary wedge pressure (PCWP) and sub-acoustic diastolic, third heart sound (S3) in the patients undergoing RHC. A total of 66 patients were enrolled. In HF patients (n = 25), change in weight was correlated with both change in device TI (Spearman correlation [rsp] = -0.64, p = 0.002) and change in device S3 (rsp = -0.53, p = 0.014). In the haemodialysis cohort (n = 21), B-lines and TI were strongly correlated before (rsp = -0.71, p < 0.001) and after (rsp = -0.77, p < 0.001) dialysis. Volume of fluid removed by dialysis was correlated with change in device TI (rsp = 0.49, p = 0.024). In the RHC cohort (n = 20), PCWP measured at one time point and device S3 were not significantly correlated (rsp = 0.230, p = 0.204). There were no device-related adverse events.

CONCLUSIONS

A non-invasive device was able to detect changes in congestion in patients with HF receiving decongestion therapy and patients having fluid removed at haemodialysis. The cardiopulmonary management device, which measures multiple parameters, is a potentially useful tool to monitor patients with HF to prevent hospitalizations.

Для цитирования: Curtain James P, Talebi Atefeh, McIntosh Alasdair, McConnachie Alex, O'Donnell Joanne, Welsh Paul, Osmanska Joanna, Lee Matthew M Y, Sonecki Piotr, Akl Tony, Seo Joohyun, Gopinathan Venugopal, Hurwitz Jed, Thiagarajan Srikanth, Pettit Stephen, Kalra Paul R, Patel Rajan K, Mark Patrick B, Lang Ninian N, McMurray John J V, Petrie Mark C, Gardner Roy S, Jhund Pardeep S. Measuring congestion with a non-invasive monitoring device in heart failure and haemodialysis: CONGEST-HF.. European journal of heart failure. 2024. DOI: 10.1002/ejhf.3290.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.